Commercial launch of a service company spun out from a big pharma

Situation

• ADME and biopharmaceutics services provider aiming at adding high value to R&D products of life sciences companies.
• The project was a spin-off from a large European pharmaceutical company.
• At inception, founders needed external support to prepare the commercial launch of the business

Bionest Contribution

• Strategic review and business planning of the future businesses
• Packaged the services offering and prepared the management team for negotiations with potential clients

Key Results

• Company was created with 20 people and a founding services contract
• Business planning work helped the company to win a €250K-grant from ANVAR, the French Innovation Agency